The death of cancer? Part 3: Searching for cure or long-term control
In a special three-part essay, ICR Chief Executive Professor Paul Workman reflects on five decades of advances in cancer treatment – inspired by The Death of Cancer, an account by clinical research pioneer and ex-Director of the US National Cancer Institute Vincent DeVita. In part three, Professor Workman explores the transition from classical chemotherapy drugs to new molecularly targeted treatments and immunotherapy – and the prospects for long-term survival and cure. He also discusses the attitudes and language that animate the drive to defeat cancer.